Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Newbury Pharmaceuticals AB | 405,000 | net | 05 Aug 2024 | tx 2+405,000 |
| Eros Capital Partners AB | 16,500 | net | 14 Apr 2023 | tx 1+16,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Aug 2024 | GRANT_AWARD | Newbury Pharmaceuticals AB | 200,000 | 0.89 SEK | deriv |
| 14 Apr 2023 | PURCHASE | Eros Capital Partners AB | 16,500 | 5.86 SEK | |
| 16 Aug 2022 | OTHER | Newbury Pharmaceuticals AB | 205,000 | 0.01 SEK |